Capricor: Maintaining 'Hold' Rating On Randomized Phase 3 HOPE-3 Trial Win With Deramiocel

Capricor: Maintaining 'Hold' Rating On Randomized Phase 3 HOPE-3 Trial Win With Deramiocel#Capricor #Maintaining #039Hold039 #Rating #Randomized #Phase #HOPE3 #Trial #Win #Deramiocel